Drug Shortage Report for GABAPENTIN
Report ID | 220627 |
Drug Identification Number | 02353253 |
Brand name | GABAPENTIN |
Common or Proper name | GABAPENTIN |
Company Name | SANIS HEALTH INC |
Market Status | MARKETED |
Active Ingredient(s) | GABAPENTIN |
Strength(s) | 300MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 700 |
ATC code | N02BF |
ATC description | |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2024-02-26 |
Estimated end date | 2024-05-23 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-02-27 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1 PRESIDENTS CHOICE CIRCLE BRAMPTON, ONTARIO CANADA L6Y 5S5 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2024-02-27 | English | Compare |
v3 | 2024-02-26 | English | Compare |
v2 | 2024-02-26 | French | Compare |
v1 | 2024-02-26 | English | Compare |
Showing 1 to 4 of 4